MIM
VIR icon

Monashee Investment Management’s Vir Biotechnology VIR Stock Holding History

Monashee Investment Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100,000
Closed -$896K – 42
2026
Q1 		$896K Buy
+100,000
New +$797K 0.49% 42

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Monashee Investment Management's VIR Position: Q2 2026 in Review

Monashee Investment Management sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 100,000 shares — an estimated $896K sold.

Monashee Investment Management first reported a position in VIR in Q1 2026 and held it in 1 quarter. The position peaked at $896K in Q1 2026. 238 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Monashee Investment Management reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Monashee Investment Management sold 100,000 Vir Biotechnology shares in Q2 2026, an estimated $896K.
  • Monashee Investment Management first reported a position in Vir Biotechnology in Q1 2026 and held it in 1 quarter.
  • Monashee Investment Management's Vir Biotechnology position peaked at $896K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Monashee Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.